Meet with the ProSciento team of experts at EASL’s International Liver Congress™ and learn about how our unparalleled NASH trial experience, proven, science-driven strategies, and specialized services benefit you, while also advancing research in biomarker discovery and disease progression.
Benefits of working with ProSciento:
- More than 12 years of experience designing and conducting NASH clinical trials
- Leading provider: more early phase NAFLD and NASH clinical trials conducted than any other U.S.-based provider
- More than 4,500 prescreened patients at-risk for NAFLD and NASH ready for your clinical trials